LYON, France, Sept. 1, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, is pleased to announce that its Chief Financial Officer, Eric Soyer, was interviewed yesterday by The Wall Street Reporter. The interview provides a corporate overview of EDAP TMS and highlights the new Focal Therapy trend in the urology community to address prostate cancer. The interview also covers EDAP's market expansion of Ablatherm-High Intensity Focused Ultrasound (HIFU) into China and recent advancements with its Sonolith i-sys and Sonolith i-move, for which the company has submitted a 510(k) application for marketing clearance to the U.S. Food & Drug Administration.
EDAP Media Interview Highlights Prostate Cancer
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.